Cell salvage in obstetrics

Haley Goucher, Cynthia A. Wong, Samir K. Patel, Paloma Toledo*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

81 Scopus citations


Intraoperative cell salvage is a strategy to decrease the need for allogeneic blood transfusion. Traditionally, cell salvage has been avoided in the obstetric population because of the perceived risk of amniotic fluid embolism or induction of maternal alloimmunization. With advances in cell salvage technology, the risks of cell salvage in the obstetric population parallel those in the general population. Levels of fetal squamous cells in salvaged blood are comparable to those in maternal venous blood at the time of placental separation. No definite cases of amniotic fluid embolism have been reported and appear unlikely with modern equipment. Cell salvage is cost-effective in patients with predictably high rates of transfusion, such as parturients with abnormal placentation.

Original languageEnglish (US)
Pages (from-to)465-468
Number of pages4
JournalAnesthesia and analgesia
Issue number2
StatePublished - Aug 25 2015

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Cell salvage in obstetrics'. Together they form a unique fingerprint.

Cite this